相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer
Dimitrios Korentzelos et al.
SCIENTIFIC REPORTS (2022)
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer
Jin Huang et al.
GUT (2021)
Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
Yuchen Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
Federica Liotti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer
Yang Chen et al.
CANCER CELL (2021)
Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-KB/STAT3 and NF-KB/CSN5 signaling pathways
Zhiyan Ruan et al.
PANCREATOLOGY (2021)
Hypoxia-Driven Oncometabolite L-2HG Maintains Sternness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer
Vineet K. Gupta et al.
CANCER RESEARCH (2021)
Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells
Alice Clare Newman et al.
MOLECULAR CELL (2021)
Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression
Kai Chen et al.
EBIOMEDICINE (2021)
NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1
Xiaozhen Zhang et al.
NATURE COMMUNICATIONS (2021)
WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape
Chunwan Lu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication
Gabriela Sarti Kinker et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Immune profiling and immunotherapeutic targets in pancreatic cancer
Felicia L. Lenzo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer
Jinyang Li et al.
CANCER DISCOVERY (2021)
The emerging role of epigenetic therapeutics in immuno-oncology
Michael J. Topper et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1
Kai Wang et al.
CANCER LETTERS (2020)
Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
Shipra Das et al.
CANCER RESEARCH (2020)
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
Nikita S. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer
Rui Yan et al.
LIFE SCIENCES (2020)
Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
Yaqing Zhang et al.
CANCER DISCOVERY (2020)
Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer
Ying Ma et al.
GASTROENTEROLOGY (2020)
Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity
Alexander H. Morrison et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
PD-L1 expression increased by IFN-γ via JAK2-STAT1 signaling and predicts a poor survival in colorectal cancer
Tiancheng Zhao et al.
ONCOLOGY LETTERS (2020)
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
Jerry B. Harvey et al.
FRONTIERS IN IMMUNOLOGY (2020)
Myeloid Cell-Derived Arginase in Cancer Immune Response
Tomasz M. Grzywa et al.
FRONTIERS IN IMMUNOLOGY (2020)
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
Reem Saleh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Restoration of miR-340 controls pancreatic cancer cellCD47expression to promote macrophage phagocytosis and enhance antitumor immunity
Qing Xi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
Wenjie Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
Tamas A. Gonda et al.
CANCER RESEARCH (2020)
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
Gemma van Duijneveldt et al.
CLINICAL SCIENCE (2020)
Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer
Yu Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC
Xiuchao Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity
Bo Wang et al.
THERANOSTICS (2020)
PD-1/PD-L1 pathway: Basic biology and role in cancer immunotherapy
Arash Salmaninejad et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer
Ping Fan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
Brian C. Miller et al.
NATURE IMMUNOLOGY (2019)
Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift
Jung Eun Park et al.
ONCOGENE (2019)
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
Jun Zhao et al.
NATURE COMMUNICATIONS (2019)
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Qiang Zhang et al.
CANCER RESEARCH (2019)
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
Heng-Huan Lee et al.
CANCER CELL (2019)
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
Alexander Thiem et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer
Daisuke Imai et al.
JOURNAL OF SURGICAL RESEARCH (2019)
USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity
Xing Huang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
IL-17 inhibits CXCL9/10-mediated recruitment of CD8+ cytotoxic T cells and regulatory T cells to colorectal tumors
Ju Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1
Emma Eriksson et al.
JOURNAL OF IMMUNOLOGY (2019)
HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer
Guofu Hu et al.
PANCREATOLOGY (2019)
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Thomas A. Mace et al.
GUT (2018)
Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3K gamma to Promote Pancreatic Cancer Metastasis
Xiaofeng Wang et al.
CANCER RESEARCH (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases
Arnaud Pommier et al.
SCIENCE (2018)
Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo
Giorgia Rota et al.
CELL REPORTS (2018)
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flavia Castro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction
Rui Feng et al.
CELL COMMUNICATION AND SIGNALING (2018)
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang et al.
CANCER CELL (2018)
The IFN-gamma/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
Jiawen Qian et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
David Balli et al.
CLINICAL CANCER RESEARCH (2017)
Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
Yaqing Zhang et al.
GUT (2017)
CD25-expressing Th17 cells mediate CD8+ T cell suppression in CTLA-4 dependent mechanisms in pancreatic ductal adenocarcinoma
Cuicui Lang et al.
EXPERIMENTAL CELL RESEARCH (2017)
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Matthew A. Coelho et al.
IMMUNITY (2017)
The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
Chunwan Lu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer
Jung-Eun Jang et al.
CELL REPORTS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
Chunwan Lu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
Eva M. Palsson-McDermott et al.
FRONTIERS IN IMMUNOLOGY (2017)
Identifying Regulatory Posttranslational Modifications of PD-L1: A Focus on Monoubiquitinaton
Henrick Horita et al.
NEOPLASIA (2017)
Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway
Yan Zhao et al.
Oncotarget (2017)
CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer
Fee Bengsch et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Comprehensive Analysis of Hypermutation in Human Cancer
Brittany B. Campbell et al.
CELL (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Shari Pilon-Thomas et al.
CANCER RESEARCH (2016)
TLR7 and TLR9 ligands regulate antigen presentation by macrophages
Teja Celhar et al.
INTERNATIONAL IMMUNOLOGY (2016)
Deubiquitination and Stabilization of PD-L1 by CSN5
Seung-Oe Lim et al.
CANCER CELL (2016)
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
Marie de Charette et al.
EUROPEAN JOURNAL OF CANCER (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia-Wei Li et al.
NATURE COMMUNICATIONS (2016)
Targeting tumor-associated macrophages to combat pancreatic cancer
Ran Cui et al.
ONCOTARGET (2016)
Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells
Nagaraj S. Nagathihalli et al.
ONCOTARGET (2016)
CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
Katelyn T. Byrne et al.
CELL REPORTS (2016)
A Metabolic immune Checkpoint: Adenosine in Tumor Microenvironment
Akio Ohta
FRONTIERS IN IMMUNOLOGY (2016)
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
Peter Bailey et al.
SCIENTIFIC REPORTS (2016)
Lack of immunoediting in murine pancreatic cancer reversed with neoantigen
Rebecca A. Evans et al.
JCI INSIGHT (2016)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages
Gregory L. Beatty et al.
GASTROENTEROLOGY (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
Theodore Kouo et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
Yu-Hwa Huang et al.
NATURE (2015)
Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia
Florencia McAllister et al.
CANCER CELL (2014)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer
Kouichirou Aida et al.
CANCER SCIENCE (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran et al.
MOLECULAR CELL (2014)
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
Jehan El-Jawhari et al.
MOLECULAR IMMUNOLOGY (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Macrophage cytokines: involvement in immunity and infectious diseases
Guillermo Arango Duque et al.
FRONTIERS IN IMMUNOLOGY (2014)
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Y. Ino et al.
BRITISH JOURNAL OF CANCER (2013)
Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance
Yaqing Zhang et al.
CANCER RESEARCH (2013)
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang et al.
CELL (2013)
Treg and CTLA-4: Two intertwining pathways to immune tolerance
Lucy S. K. Walker
JOURNAL OF AUTOIMMUNITY (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
Esra A. Akbay et al.
CANCER DISCOVERY (2013)
Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
Robert H. Vonderheide et al.
ONCOIMMUNOLOGY (2013)
Genetically Engineered Mouse Models of Pancreatic Cancer
Christoph Benedikt Westphalen et al.
CANCER JOURNAL (2012)
Metabolic switching and fuel choice during T-cell differentiation and memory development
Gerritje J. W. van der Windt et al.
IMMUNOLOGICAL REVIEWS (2012)
Prostaglandin E2 and T cells: friends or foes?
Vinatha Sreeramkumar et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation
Anna N. Mendler et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The TIGIT/CD226 Axis Regulates Human T Cell Function
Ester Lozano et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
Shigeki Chiba et al.
NATURE IMMUNOLOGY (2012)
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
Marina Lesina et al.
CANCER CELL (2011)
IL-18 Induces PD-1-Dependent Immunosuppression in Cancer
Magali Terme et al.
CANCER RESEARCH (2011)
Vstm3 is a member of the CD28 family and an important modulator of T-cell function
Steven D. Levin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
Ruoning Wang et al.
IMMUNITY (2011)
Regulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase
Daniel R. Sharda et al.
JOURNAL OF IMMUNOLOGY (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
Lck and the nature of the T cell receptor trigger
Simon J. Davis et al.
TRENDS IN IMMUNOLOGY (2011)
Epidermal Growth Factor Receptor in Pancreatic Cancer
Melissa Oliveira-Cunha et al.
Cancers (2011)
High Levels of Expression of Human Stromal Cell-Derived Factor-1 Are Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
John J. Liang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
Human Prostate-Infiltrating CD8+ T Lymphocytes are Oligoclonal and PD-I+
Karen S. Sfanos et al.
PROSTATE (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
Phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of oral alvespimycin (A; KOS-1022; 17-DMAG): Two different schedules in patients with advanced malignancies
K. T. Flaherty et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody
Robert H. Vonderheide et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPβ
MJ Gray et al.
GENE (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Differential expression of CTLA-4 among T cell subsets
CB Jago et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
T Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells
LH Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2000)
Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin
K Delp et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
